COMBINED THERAPY INCLUDING VEMURAFENIB AND INTERFERON, FOR USE IN TREATING CANCER Russian patent published in 2016 - IPC A61K31/437 A61K38/21 A61P35/00 

FIELD: medicine.

SUBSTANCE: group of inventions relates to a combined therapy of solid tumour or cancer. Disclosed are: pharmaceutical product in form of combined preparation for specified application, containing as an active agent {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl-2,4-difluoro-phenyl]-amide}propane-1-sulphonic acid or its pharmaceutically acceptable salt and peg-interferon alpha-2a; set of same application, including said active agents; use of {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl-2,4-difluoro-phenyl]-amide}propane-1-sulphonic acid or its salts and peg-interferon alpha-2a in treating solid tumour or cancer; use of {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl-2,4-difluoro-phenyl]-amide}propane-1-sulphonic acid or its salts and peg-interferon alpha-2a for preparing a drug for treating solid tumour or cancer.

EFFECT: longer life of patients.

18 cl, 6 dwg, 10 tbl